Freenome logo

Freenome

South San Francisco, CA

Freenome, Inc. provides clinical research services. The Company develops and creates screening, diagnosis, and treatment of age-associated clinical conditions. Freenome serves patients and the healthcare sector in the United States.

freenome.com

Company Details

Founded

2014

Employees

Between 100 - 500 employees

Raised

$1,451,550,080

Headquarters Location

South San Francisco, CA

Public

No

Acquired

No

CEO

Aaron ElliottAaron Elliott

Founders

Riley Ennis
Riley Ennis
Gabriel Otte
Gabriel Otte
Charles Roberts
Charles Roberts
Michael Otte
Michael Otte

Company Collections

These are collections Freenome is a part of. Click on the collection name to view similar companies.

Current Job Listings

Listing 0 of 34 job openings

    Freenome Headquarters Location

    259 E Grand Av, South San Francisco, CA 94080-4804

    Total Amount Raised: $1,451,550,080

    Freenome Funding Rounds

    • Convertible Note

      $50,000,000

      Convertible Note Investors

      Exact Sciences
    • Corporate Round

      $50,000,000

      Corporate Round Investors

      Exact Sciences
    • Series Unknown

      $254,000,000

      Series Unknown Investors

      Roche
      Intermountain Ventures
      Eventide
      Squarepoint Capital
      Polaris Partners
      Bain Capital Life Sciences
      RA Capital Management
      Cormorant Capital
      DCVC Bio
      Perceptive Advisors
      Quest Diagnostics
      Pura Vida Investments
      Andreessen Horowitz
      Artis Ventures
      Sands Capital Management
      S32
      ArrowMark Colorado Holdings
      T. Rowe Price
      BrightEdge Fund
      ARK Investment Management
    • Corporate Round

      $290,000,000

      Corporate Round Investors

      Roche
    • Series D

      $300,000,000

      Series D Investors

      Perceptive Advisors
      RA Capital Management
      Andreessen Horowitz
      BrightEdge Fund
      Catalio Capital Management
      Bain Capital Life Sciences
      Artis Ventures
      Cormorant Capital
      DCVC
      Fidelity
      Farallon Capital Management
      Henderson Global Investors
      Kaiser Permanente
      Novartis
      Ridgeback Capital Management
      Polaris Partners
      Roche Venture Fund
      Rock Springs Capital
      S32
      Sands Capital Management
      T. Rowe Price
      Soleus Capital
      ArrowMark Colorado Holdings
      HBM Healthcare Investments
      Byers Capital
      Eventide
      Intermountain Ventures
      Suvretta Capital Management
      Logos Capital
      Pura Vida Investments
      GV
    • Series C

      $270,000,000

      Series C Investors

      Bain Capital Life Sciences
      Perceptive Advisors
      RA Capital Management
      Farallon Capital Management
      Fidelity
      Henderson Global Investors
      BrightEdge Fund
      Catalio Capital Management
      Cormorant Asset Management
      EcoR1 Capital
      Rock Springs Capital
      Andreessen Horowitz
      Sands Capital Management
      DCVC
      Novartis
      GV
      Soleus Capital
      Roche Venture Fund
      Kaiser Permanente Ventures
      S32
      Polaris Partners
      T. Rowe Price
    • Series B

      $160,000,000

      Series B Investors

      Polaris Partners
      RA Capital Management
      T. Rowe Price
      Perceptive Advisors
      Verily
      S32
      BrightEdge Fund
      Andreessen Horowitz
      DCVC
      Kaiser Permanente Ventures
      Roche Venture Fund
      GV
      Longevity Vision Fund
      Soleus Capital
      Artis Ventures
      dRx Capital
    • Series A

      $7,000,000

      Series A Investors

      S32
      Anne Wojcicki
      Andreessen Horowitz
      Asset Management Ventures
      DCVC
      Founders Fund
      Innovation Endeavors
      Polaris Partners
      S28 Capital
      Verily
      GV
      CRV
    • Series A

      $65,000,000

      Series A Investors

      Andreessen Horowitz
      GV
      Polaris Partners
      Innovation Endeavors
      S28 Capital
      Asset Management Ventures
      CRA International
      AME Cloud Ventures
      Allen & Company
      DCVC
      Founders Fund
      Agent Capital
    • Seed

      $5,550,000

      Seed Investors

      Andreessen Horowitz
      Founders Fund
      DCVC
      Third Kind Venture Capital
    Funding info provided by Diffbot.

    Freenome Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Freenome.

    Recent reviews